ClinicaliQ Trial Snapshot
- A Study to Evaluate ALN-4915 in Adult Healthy Volunteers — Recruiting • Phase I • NCT07535606.
- A study testing a new drug called ALN-4915 in healthy adults to check if it's safe and how the body processes it.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The purpose of this study is to evaluate the safety, tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) of ALN-4915. Conditions: Healthy Volunteers Interventions: ALN-4915, Placebo Lead Sponsor: Alnylam Pharmaceuticals Planned Enrollment: 44 participants